Skeletal Muscle Relaxant Pharm Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Nondepolarizing Neuromuscular Blockers

Mechanism of Action, Adverse Effects (4)

A

Competitive nAchR antagonist

Hypotension
Tachycardia
Bronchospasm
Increased secretions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Isoquinolone Nondepolarizing Agents

Examples (5) with Duration of Action

A

Atracurium: intermediate

Cisatracurium: intermediate

Doxacurium: long

Mivacurium: short

Tubocurarine: long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Steroid Nondepolarizing Agents

Examples (4) with Duration of Action

A

Pancuronium: long

Pipecuronium: long

Rocuronium: intermediate

Vecuronium: intermediate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Succinylcholine
Classification, Duration of Action, Adverse Effects (3) Contraindication, Black Box Warning
MOA: Phase 1 (2) Phase 2 (3)

A

Depolarizing Neuromuscular blocker

Ultra-short acting

Cardiac arrhythmias
Hyperkalemia
Increased Intraocular Pressure

Malignant hypertension

Risk of Cardiac arrest

Phase 1:
Activated Achr causing NMJ depolarization
Flaccid paralysis caused by lack of repolarization

Phase 2:
Continued exposure causes decreased depolarization and membrane repolarizes
Receptor acts as if in prolonged closed state
Receptor desensitized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Neuromuscular Blocking Drugs

Indications (4)

A

Surgical relaxation (long acting drugs)
Tracheal intubation (short acting drugs)
Control of ventilation
Treatment of convulsions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acetylcholinesterase Inhibitors

Examples (10)

A

Ambenonium
Edrophonium

Echothiophate
Donepezil
Tacrine

Galantamine
Neostigmine
Physostigmine
Pyridostigmine
Rivastigmine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acetylcholinesterase Inhibitors
Succinylcholine Adjunct Uses (2)
Therapeutic Uses (5)
Adverse Effects (2)

A

Phase 1: Augments blockade
Phase 2: Antagonizes blockade

Myasthenia gravis
Reversal of pharmacologic paralysis
Glaucoma
Dementia
Antidote to anticholinergic poisoning
CNS hyperstimulation (lipid soluble agents)
PSNS Effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Baclofen

Classification, Mechansim of Action (2) Adverse Effects (2)

A

Centrally acting spasmolytic agent

GABA-b agonist
Inhibits excitatory neurotransmitter release

Seizures (in epileptics)
Psych issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Carisoprodol

Classification, Adverse Effect, Metabolism

A

Centrally acting spasmolytic agent

Addictive

Metabolized by CYP2C19 to anxiolytic meprobamate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cyclobenzaprine

Classification, Brand Name, Metabolism, Adverse Effects (3)

A

Centrally acting spasmolytic agent

Flexeril

CYP450 metabolized

Drowsiness
Dizziness
Xerostomia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diazepam

Classification, MOA, Adverse Effects (2)

A

Centrally acting spasmolytic agent

Enhances GABAa receptor activity in presence of GABA

CNS depression
Sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tizanidine

Classification, MOA, Adverse Effects (4)

A

Centrally acting spasmolytic agent

Alpha-2 agonist

Drowsiness
Hypotension
Dry mouth
Muscle weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dantrolene

Classification, MOA (2) Indication, Adverse Effects (3)

A

Non-Centrally acting spasmolytic agent

Inhibits ryanodine receptor
Blocks SR release of Calcium

Malignant Hyperthermia cure

Muscle Weakness
Sedation
Hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Botulinum Toxin

Classification, MOA (2) Indications (4) Adverse Effect

A

Non-Centrally acting spasmolytic agent

Cleaves VAMP to block vesicular release of Ach

Dystonia (strabismus, blepharospasm)
Primary Axillary Hyperhidrosis
Chronic Migraine
Focal Spasticity

Focal Muscle Weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Multiple Sclerosis Treatments

Drugs (4) with Mechanisms of Action (1/2/1/1)

A

Glucocorticoids: immunosuppression

Interferons: Bind VLA-4 on T cells to stop adhesion or stopping MMP expression by T cells

Glatiramer Acetate: induce T cell suppressor cells for myelin proteins

Mitoxantrone: intercalates with DNA causing strand breaks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Myasthenia Gravis

Treatment (3) Drug Interaction With Disease

A

Pyridostigmine
Neostigmine
Ambenonium

Enhances neuromuscular blockade of non-depolarizing agents

17
Q

Anti-Muscarinic Agents

Examples (2) MOA, and Use (2)

A

Atropine
Glycopyrrolate

Muscarinic antagonist

Given with Acetylcholinesterase inhibitors to reverse skeletal muscle paralysis
Decrease Acetylcholinesterase inhibitor side effects